Oppenheimer analyst Matthew Biegler reiterated a Hold rating on Day One Biopharmaceuticals (DAWN – Research Report) yesterday. The company’s ...
1d
Hosted on MSNOppenheimer Upgrades BioMarin Pharmaceutical (BMRN)Fintel reports that on February 24, 2025, Oppenheimer upgraded their outlook for BioMarin Pharmaceutical (NasdaqGS:BMRN) from ...
Efforts are ongoing to rehabilitate the Oppenheimer Beach Facility on the island of St. John thanks to a $1 million grant ...
Freshpet (NASDAQ:FRPT – Get Free Report) had its price target dropped by research analysts at Oppenheimer from $180.00 to ...
The women filed the lawsuit last Friday against the Milwaukee Bucks, former Bucks guard Patrick Beverley and assistant coach ...
Oppenheimer upgraded BioMarin (BMRN) to Outperform from Perform with a $98 price target BioMarin reported strong Q4 results and Oppenheimer ...
As NVIDIA increases the output of its next-generation Blackwell architecture, its AI hardwareespecially its H200 GPUsis ...
(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...
5don MSN
Rupesh Parikh, Oppenheimer managing director and senior analyst, joins 'Squawk Box' to break down Walmart's quarterly ...
Two Indiana Pacers fans have sued the Milwaukee Bucks and Patrick Beverley after the point guard threw a ball into the stands ...
Nvidia is set to report fourth-quarter results after the market closes Wednesday, with analysts widely bullish on the AI chipmaker's stock.
Performant Healthcare, Inc. (Nasdaq: PHLT) (“Performant”), a leading provider of technology-enabled payment integrity, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results